NASDAQ:OTLK

Outlook Therapeutics Stock Predictions

etoro logo Buy OTLK
*Your capital is at risk
$0.81
-0.0038 (-0.467%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

OTLK Prediction Chart

OTLK Predictions History

Latest community submissions for OTLK.
Predictor Target Session Target Price Result Direction Accuracy Score
Aug 28, 2025 Bullish $1.09 X 0
Aug 26, 2025 $2.87 -3.31% $2.70 V 93.64% 1
Aug 26, 2025 $2.91 -2.07% $2.70 V 92.27% 1
Aug 26, 2025 $3.33 +12.12% $2.70 X 76.67% 0
Aug 25, 2025 $2.58 -3.57% $2.97 X 87.01% 0
Aug 25, 2025 $2.62 -2.23% $2.97 X 88.22% 0
Aug 25, 2025 $3.01 +12.31% $2.97 V 98.65% 2
Aug 20, 2025 $3.00 +14.07% $2.39 X 74.48% 0
Aug 20, 2025 $2.54 -3.37% $2.39 V 93.67% 1
Aug 20, 2025 $2.57 -2.11% $2.39 V 92.28% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for OTLK with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT OUTLOOK THERAPEUTICS INC.
Outlook Therapeutics
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE